, Tracking Stock Market Picks
Enter Symbol:
Medicinova, Inc. (MNOV) [hlAlert]

up 23.23 %

Medicinova, Inc. (MNOV) rated Buy with price target $4 by Global Hunter Securities

Posted on: Wednesday,  Jun 22, 2011  8:25 AM ET by Global Hunter Securities

Global Hunter Securities rated Buy Medicinova, Inc. (NASDAQ: MNOV) on 06/22/2011, when the stock price was $2.41. Since
then, Medicinova, Inc. has gained 23.24% as of 08/27/2015's recent price of $2.97.
If you would have followed this Global Hunter Securities's recommendation on MNOV, you would have gained 23.23% of your investment in 1527 days.

Medicinova, Inc., incorporated in September 2000, is a biopharmaceutical company focused on acquiring and developing small molecule therapeutics for the treatment of diseases with unmet medical need with a specific focus on the United States market. Through strategic alliances primarily with Japanese pharmaceutical companies, the Company is developing a portfolio of clinical and preclinical product candidates. Medicinova has acquired licenses to eight compounds for the development of 10 product candidates. Its development pipeline includes eight programs which have been in clinical development for the treatment of asthma, acute exacerbations of asthma, multiple sclerosis, or MS, interstitial cystitis (IC), solid tumor cancers, Generalized Anxiety Disorder/insomnia, preterm labor and urinary incontinence. The Company is focused on the development of two prioritized assets in its development pipeline: MN-221 for the treatment of status asthmaticus, and MN-166 for the treatment of MS.

Global Hunter Securities uses a disciplined quantitative and qualitative approach, our analysts are focused on covering small-cap companies with unique value and above average growth, primarily in the following sectors: Consumer, Energy, Healthcare, Industrial, Services and Technology. Additionally, Global Hunter Securities has analysts specifically focused on Special Situations and International opportunities. Global Hunter Securities' analysts maintain strong relationships and ongoing dialogue with management teams and industry professionals to ensure propitious access to information.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/22/2011 8:25 AM Buy
2.41 4.00
as of 12/30/2011
1 Week down  -6.59 %
1 Month down  -17.47 %
3 Months down  -20.93 %
1 YTD down  -29.46 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy